Shares of other companies:
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
Apple’s Technical Climb To $240 By Year-End
April 15, 2024
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
MASI Stock News and Mentions of Masimo Corporation Stocktwits
Updated: April 19, 2024 (09:58)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Masimo Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Masimo Corporation (MASI).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Masimo stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Masimo Corporation (MASI)
April 17, 2024 (11:43) / "Zacks Commentary" (by Zacks Equity Research)
Masimo ( MASI ) Gains Nearly 18% YTD: What's Driving the Rally?
Masimo's (MASI) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.
In Article Trend: Somewhat-Bullish
April 16, 2024 (18:04) / "Zacks Commentary" (by Zacks Equity Research)
Is a Beat Likely for Intuitive Surgical ( ISRG ) in Q1 Earnings?
Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.
In Article Trend: Somewhat-Bullish
April 16, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks Showing Rising Market Leadership: Masimo Earns 82 RS Rating
When putting together your watch list, look for stocks with an 80 or higher RS Rating. Masimo ( MASI ) just cleared that benchmark with an upgrade from 78 to 82. X This exclusive rating from Investor's Business Daily measures market leadership with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Somewhat-Bullish
April 15, 2024 (12:39) / "Benzinga" (by Avi Kapoor)
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday - Cisco Systems ( NASDAQ:CSCO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo boosted the price target for Centene Corporation CNC from $89 to $93.
In Article Trend: Neutral
April 9, 2024 (13:51) / "Motley Fool" (by Motley Fool Staff)
How's AT&T Handling Things?
We've also got a look at 3M's spinoff, gold prices, and the beef industry.
In Article Trend: Somewhat-Bullish
April 6, 2024 (12:15) / "Motley Fool" (by Motley Fool Staff)
Can a New CEO Fix Boeing?
We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding.
In Article Trend: Somewhat-Bullish
April 6, 2024 (10:30) / "Motley Fool" (by Motley Fool Staff)
Boeing's Leadership Shake-Up
And IWG CEO Mark Dixon talks with us about the global shift toward hybrid work.
In Article Trend: Somewhat-Bullish
April 6, 2024 (07:25) / "Benzinga" (by Ananya Gairola)
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches - Masimo ( NASDAQ:MASI )
Apple Inc. AAPL has appealed to a U.S. appeals court to reverse a ban on the import of certain Apple Watches. The ban was imposed following a patent dispute with medical-monitoring technology company Masimo Corporation MASI. What Happened: On Friday, Apple requested the U.S.
In Article Trend: Somewhat-Bearish
April 4, 2024 (12:50) / "Zacks Commentary" (by Zacks Equity Research)
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
In Article Trend: Bullish
March 29, 2024 (06:12) / "Stocknews.com" (by Defense World Staff)
Masimo ( NASDAQ:MASI ) Rating Increased to Hold at StockNews.com
Masimo ( NASDAQ:MASI - Get Free Report ) was upgraded by StockNews.com from a "sell" rating to a "hold" rating in a research report issued to clients and investors on Friday. A number of other analysts have also weighed in on the company.
In Article Trend: Somewhat-Bullish
March 28, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Masimo Earns IBD Rating Upgrade
The Relative Strength ( RS ) Rating for Masimo ( MASI ) jumped into a new percentile Thursday, as it got a lift from 68 to 79. X This exclusive rating from Investor's Business Daily tracks share price action with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Bullish
March 27, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)
Is Masimo ( MASI ) Stock Outpacing Its Medical Peers This Year?
Here is how Masimo (MASI) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.
In Article Trend: Somewhat-Bullish
March 27, 2024 (11:12) / "Zacks Commentary" (by Zacks Equity Research)
Masimo ( MASI ) Plans Consumer Business Spin-Off to Drive Growth
Masimo (MASI) is evaluating a proposed separation of its consumer audio and consumer health product business in a bid to improve the profitability of the healthcare business.
In Article Trend: Somewhat-Bullish
March 26, 2024 (13:36) / "Zacks Commentary" (by Zacks Equity Research)
March 26, 2024 (13:02) / "Investors Business Daily" (by ALLISON GATLIN)
Viking Surges After Weight-Loss Pill Beats Forecasts In Just 28 Days
Viking Stock Surges After Weight-Loss Drug Tops Expectations Investor's Business Daily ...
In Article Trend: Neutral
March 26, 2024 (11:06) / "Zacks Commentary" (by Zacks Equity Research)
Masimo ( MASI ) Soars 3.3%: Is Further Upside Left in the Stock?
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
In Article Trend: Somewhat-Bullish
March 25, 2024 (15:05) / "Investors Business Daily" (by ALLISON GATLIN)
Masimo Breaks Out On Potential Separation; But Will Profits Hold Up?
Masimo Stock Breaks Out On Potential Consumer-Business Separation Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
March 25, 2024 (14:01) / "CNBC" (by Rohan Goswami)
Activist investor plans second fight at Masimo, sending shares up 12%
Quentin Koffey's Politan Capital waged a successful proxy fight at Masimo last year, and it is now seeking two more board seats.
In Article Trend: Neutral
March 25, 2024 (13:02) / "CNBC" (by Jim Cramer)
Jim Cramer's top 10 things to watch in the stock market Monday
Stock futures were slightly lower to kick off the last week of March and the first quarter.
In Article Trend: Neutral
March 25, 2024 (12:51) / "Benzinga" (by Akanksha Bakshi)
Bitcoin, Ethereum, Dogecoin Gain Momentum As Fresh Trading Week Starts: Analyst Says Altcoin Market 'Bottoming Out,' Eyes $70K For BTC This Wee; Boeing Labor Union Pushes For Board Voice: Report - Top Headlines Today While US Was Sleeping
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session Investor Sentiment Falls, But Dow Records Strongest Week Since December Will Trump Pull The Bankruptcy Trigger Before NY Civil Fraud Case Deadline? DOJ Veteran Expects A 'Deus Ex Machina' From Third ...
In Article Trend: Somewhat-Bullish
March 25, 2024 (12:39) / "Benzinga" (by Avi Kapoor)
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday - Walt Disney ( NYSE:DIS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Stephens & Co. cut the price target for Centene Corporation CNC from $92 to $85.
In Article Trend: Somewhat-Bullish
March 25, 2024 (12:05) / "Benzinga" (by Vandana Singh)
Patient Monitoring Device Maker Masimo Contemplates Separation of Consumer Business As Activist Investor Seeks Expanded Board Presence - Masimo ( NASDAQ:MASI )
Monday, activist investor Quentin Koffey, the founder of Politan Capital Management, nominated two candidates for election to the Masimo Board of Directors at the upcoming 2024 Annual Meeting of Stockholders.
In Article Trend: Somewhat-Bullish
March 25, 2024 (11:40) / "Benzinga" (by Shanthi Rexaline)
Nasdaq, S&P 500 To Open Fresh Week In The Red: What's Moving Stock Futures? - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )
Major U.S. index futures edged lower on Monday, reflecting the cautious mood from last week's close. The tech sector could face additional pressure due to China's plan to phase out U.S. chipmakers from government PCs and servers. Three upcoming Fed speeches this week may offer clues about future ...
In Article Trend: Neutral
March 25, 2024 (09:34) / "Benzinga" (by Avi Kapoor)
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session - Esperion Therapeutics ( NASDAQ:ESPR ) , Masimo ( NASDAQ:MASI )
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. ESPR rose sharply in today's pre-market trading. The U.S.
In Article Trend: Bullish
March 25, 2024 (06:50) / "Benzinga" (by Avi Kapoor)
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday - Dada Nexus ( NASDAQ:DADA )
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Dada Nexus Limited DADA to report quarterly earnings at 9 cents per share on revenue of $432.74 million after the closing bell, according to data ...
In Article Trend: Somewhat-Bullish
March 22, 2024 (09:48) / "Stocknews.com" (by Defense World Staff)
Masimo ( NASDAQ:MASI ) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of Masimo ( NASDAQ:MASI - Free Report ) from a hold rating to a sell rating in a research report report published on Thursday. MASI has been the subject of several other research reports.
In Article Trend: Somewhat-Bullish
March 22, 2024 (01:00) / "Benzinga" (by Globe Newswire)
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Masimo ( NASDAQ:MASI )
NEW YORK, March 21, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Masimo Corporation MASI on behalf of long-term stockholders following a class action complaint that was filed against Masimo ...
In Article Trend: Neutral
March 19, 2024 (11:59) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Add Masimo ( MASI ) to Your Portfolio Now
Masimo's (MASI) R&D activities raise optimism about the stock.
In Article Trend: Somewhat-Bullish
March 16, 2024 (18:22) / "Forbes" (by David Phelan)
Apple Watch Ultra 2 Controversial Feature May Return In Months
The saga of the Apple Watch and blood oxygen monitoring continues, and two new reports indicate that the now-missing feature will return, and there's even a workaround to get it back now, it seems. Here's all you need to know.
In Article Trend: Neutral
March 15, 2024 (12:46) / "Benzinga" (by Akanksha Bakshi)
Bitcoin, Ethereum, Dogecoin Trade Mixed After Hotter Inflation Data; Trump Or Biden? New Poll Reveals Which 2024 Candidate Voters With Crypto Holdings Surprisingly Prefer - Top Headlines Today While US Was Sleeping
Bitcoin's Recent Rally Could Trigger Potential Upswing In Luxury Watch Prices, Echoing 2021 Pattern: Report Bitcoin's Record Rally Could Face Turmoil From Microstrategy's Debt-Fueled Buys, Warns JPMorgan Bitcoin Plunges 8% To Below $67K: Did Inflation Just KO The Crypto King?
In Article Trend: Neutral
March 15, 2024 (04:23) / "Benzinga" (by Ananya Gairola)
Apple Watch 2.0? New Patents Hint At Expansion Beyond Health Tracking After Masimo Fiasco - Apple ( NASDAQ:AAPL ) , Masimo ( NASDAQ:MASI )
Apple Inc. AAPL has reportedly been exploring the integration of a diverse range of sensors into its Apple Watch, with a focus on non-health-related functionalities.
In Article Trend: Neutral
March 11, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)
Is Masimo ( MASI ) Outperforming Other Medical Stocks This Year?
Here is how Masimo (MASI) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.
In Article Trend: Somewhat-Bullish
March 1, 2024 (08:44) / "Stocknews.com" (by ABMN Staff)
Masimo ( NASDAQ:MASI ) Stock Rating Upgraded by StockNews.com
Masimo ( NASDAQ:MASI ) Stock Rating Upgraded by ...
In Article Trend: Somewhat-Bullish
March 1, 2024 (08:42) / "Stocknews.com" (by Defense World Staff)
Masimo ( NASDAQ:MASI ) Upgraded at StockNews.com
Masimo ( NASDAQ:MASI - Get Free Report ) was upgraded by research analysts at StockNews.com from a "sell" rating to a "hold" rating in a report issued on Wednesday. Other equities research analysts have also issued research reports about the stock.
In Article Trend: Somewhat-Bullish
February 28, 2024 (14:04) / "Zacks Commentary" (by Zacks Equity Research)
Masimo ( MASI ) Q4 Earnings Beat Estimates, Margins Decline
Despite strength in the Hearables category, Masimo's (MASI) overall fourth-quarter results reflect soft performances.
In Article Trend: Neutral
February 27, 2024 (23:00) / "Zacks Commentary" (by Zacks Equity Research)
Masimo ( MASI ) Beats Q4 Earnings and Revenue Estimates
Masimo (MASI) delivered earnings and revenue surprises of 31.58% and 0.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
February 23, 2024 (14:40) / "Zacks Commentary" (by Zacks Equity Research)
Are Medical Stocks Lagging Masimo ( MASI ) This Year?
Here is how Masimo (MASI) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year.
In Article Trend: Somewhat-Bullish
February 21, 2024 (14:43) / "Zacks Commentary" (by Zacks Equity Research)
Masimo ( MASI ) , UCHealth Unite to Improve Care With Telehealth
Masimo (MASI) collaborates with UCHealth to boost patient care by combining its latest virtual care technologies with UCHealth's clinical expertise and telehealth innovations.
In Article Trend: Bullish
February 20, 2024 (17:30) / "Motley Fool" (by Motley Fool Transcribing)
Medtronic ( MDT ) Q3 2024 Earnings Call Transcript
MDT earnings call for the period ending December 31, 2023.
In Article Trend: Somewhat-Bullish
February 20, 2024 (15:00) / "Zacks Commentary" (by Zacks Equity Research)
Earnings Preview: Masimo ( MASI ) Q4 Earnings Expected to Decline
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website